Xylo Technologies (XYLO) Stock Price, News & Analysis

Company Overview

Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Key Stats

• Today's Range: $5.12 to $5.12
• 50-Day Range: $4.81 to $5.53
• 52-Week Range: $2.70 to $8.83
• Volume: 874 shs
• Average Volume: 20,460 shs
• Market Capitalization: $4.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

XYLO Stock Analysis - Frequently Asked Questions

How have XYLO shares performed this year?

Xylo Technologies' stock was trading at $3.62 at the beginning of the year. Since then, XYLO stock has increased by 47.4% and is now trading at $5.3350.
View the best growth stocks for 2025 here.

When did Xylo Technologies' stock split?

Xylo Technologies shares reverse split before market open on Monday, August 5th 2024. The 1-2.666666 reverse split was announced on Monday, August 5th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 5th 2024. An investor that had 100 shares of stock prior to the reverse split would have 38 shares after the split.

How do I buy shares of Xylo Technologies?

Shares of XYLO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Xylo Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Xylo Technologies investors own include Upexi (UPXI), Tesla (TSLA), Siyata Mobile (SYTA), Soluna (SLNH), Rexahn Pharmaceuticals (REXN), NRx Pharmaceuticals (NRXP) and NeuroOne Medical Technologies (NMTC).

Company Calendar

• Today: 5/18/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Data processing & preparation
• Sub-Industry: Business Services
• Current Symbol: NASDAQ:XYLO
• Previous Symbol: NASDAQ:XYLO
• CIK: 1618500
• Web: www.medigus.com
• Phone: 972-3689-9124
• Fax: 972-8853-8194
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.10
• Current Ratio: 0.95
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $29.86 million
• Price / Sales: 0.15
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $46.35 per share
• Price / Book: 0.12

Miscellaneous

• Outstanding Shares: 826,000
• Free Float: 705,000
• Market Cap: $4.41 million
• Optionable: Optionable
• Beta: 0.49